Related Experiment Videos
Serum thyroxine concentrations after radioactive iodine therapy in cats with hyperthyroidism
Summary
Radioactive iodine (131I) therapy effectively and rapidly lowers thyroxine (T4) levels in hyperthyroid cats. Most cats achieved normal T4 concentrations within days, with significant clinical improvement observed one month post-treatment.
Area of Science:
- Veterinary Medicine
- Endocrinology
- Nuclear Medicine
Background:
- Hyperthyroidism is a common endocrine disorder in cats.
- Elevated serum thyroxine (T4) concentrations characterize feline hyperthyroidism.
- Radioactive iodine (131I) therapy is a treatment option for hyperthyroidism.
Purpose of the Study:
- To evaluate the efficacy and safety of a single dose of radioactive iodine (131I) in treating feline hyperthyroidism.
- To assess the rate of serum thyroxine (T4) concentration decrease following 131I administration.
- To determine the long-term clinical and biochemical outcomes of 131I therapy in cats.
Main Methods:
- Thirty-one hyperthyroid cats received a single intravenous dose of 131I.
- Serum T4 concentrations were monitored at various intervals post-treatment.
- Thyroid radiation dose was standardized to 20,000 rads.
Main Results:
- Serum T4 concentrations decreased most rapidly within the first 3 to 6 days post-treatment.
- By day 4, 55% of cats had normal T4 levels; by day 8, 74% were euthyroxinemic.
- One month post-treatment, 83% of cats had normal T4 levels, with significant clinical improvement.
Conclusions:
- Radioactive iodine (131I) administration is a safe and effective treatment for feline hyperthyroidism.
- 131I therapy provides a rapid and significant reduction in serum T4 concentrations.
- The treatment leads to sustained euthyroxinemia and clinical improvement in the majority of treated cats.